[18F]FET PET is a useful tool for treatment evaluation and prognosis prediction of anti-angiogenic drug in an orthotopic glioblastoma mouse model

[18F]FET PET is a useful tool for treatment evaluation and prognosis prediction of anti-angiogenic drug in an orthotopic glioblastoma mouse model

Abstract O-2-18F-fluoroethyl-l-tyrosine ([18F]FET) has been widely used for glioblastomas (GBM) in clinical practice, although evaluation of its applicability in non-clinical research is still lacking. The objective of this study was to examine the value of [18F]FET for treatment evaluation and prog...

Full description

Bibliographic Details
Main Authors: Ok-Sun Kim, Jang Woo Park, Eun Sang Lee, Ran Ji Yoo, Won-Il Kim, Kyo Chul Lee, Jae Hoon Shim, Hye Kyung Chung
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Laboratory Animal Research
Subjects:
[18F]FET PET
glioblastoma
bevacizumab
anti-angiogenic drug
orthotopic model
Online Access:http://link.springer.com/article/10.5625/lar.2018.34.4.248

Internet

http://link.springer.com/article/10.5625/lar.2018.34.4.248

Similar Items